Lupin will manufacture biosimilar ranibizumab while SteinCares handles registration and marketing in Latin America, excluding ...

Lupin Limited partners with SteinCares to license and supply ranibizumab in Latin America, excluding Mexico and Argentina.

Lupin has signed a licence and supply agreement with SteinCares to commercialise its biosimilar ranibizumab in Latin America.

Lupin partners with SteinCares to commercialize Ranibizumab in Latin America, aiming to improve retinal care access.

Lupin has signed an agreement with SteinCares for the commercialization of biosimilar ranibizumab in Latin America, excluding ...

Lupin has entered into a licence agreement with SteinCares for commercialisation of biosimilar ranibizumab across Latin ...

Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial ...

Lupin partners with SteinCares to commercialize biosimilar ranibizumab in Latin America, enhancing retinal care access in the region.

Lupin and SteinCares ink license and supply agreement for ranibizumab in Latin America: Our Bureau, Mumbai Monday, May 26, 2025, 14:10 Hrs [IST] Global Pharma major Lupin Limited ...

At at Good Samaritan Hospital in Puyallup, Dr. Abhishek Biswas, a pulmonologist with Multicare Health, explains how the ION robotic system enables minimally invasive lung biopsies. The ION system is ...

To improve the end-to-end permitting experience for customers and staff, the City of South San Francisco has selected Clariti's Enterprise permitting software to manage all aspects of the community ...